S. 660Senate112th Congress (2011-2013)In Committee

PATIENTS Act of 2011

Sponsored by Jon KylSen. Jon Kyl (R-AZ)
Introduced March 29, 2011

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1935)

March 29, 2011

View full timeline
SenateIntro Referral

Introduced in Senate

March 29, 2011

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1935)

March 29, 2011

Floor Debate

6 members

What members said about S. 660 on the floor

4 Republicans2 Democrats
Jeff Sessions
Sen. Jeff SessionsR-AL · Mar 29, 2011

Mr. President, I seek recognition today to introduce and speak in favor of the Finding Fugitive Sex Offenders Act of 2011, which would give administrative subpoena authority to the Director of the…

Susan M. Collins
Sen. Susan M. CollinsR-ME · Mar 29, 2011

Mr. President, I rise today to join with my colleague from Washington in introducing legislation, the Home Health Care Access Protection Act of 2011, to prevent future unfair administrative cuts in…

Olympia J. Snowe
Sen. Olympia J. SnoweR-ME · Mar 29, 2011

Mr. President, I rise today in support of the Selecting Employment Clusters to Organize Regional Success, SECTORS, Act, which Senator Sherrod Brown and I are introducing. This legislation would amend…

John D. Rockefeller IV
Sen. John D. Rockefeller IVD-WV · Mar 29, 2011

Mr. President, today I am introducing legislation to extend the Section 45G short line freight railroad tax credit. Section 45G creates an incentive for short lines to invest in track rehabilitation…

Jon Kyl
Sen. Jon KylR-AZ · Mar 29, 2011

Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.

Show 2 more
Max Baucus
Sen. Max BaucusD-MT · Mar 29, 2011

Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.

Jon Kyl
Sen. Jon KylR-AZ · Mar 29, 2011

Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued March 29, 2011

II

112th CONGRESS

1st Session

S. 660

IN THE SENATE OF THE UNITED STATES

March 29, 2011

Mr. Kyl (for himself, Mr. McConnell, Mr. Barrasso, Mr. Coburn, Mr. Crapo, and Mr. Roberts) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response.

1.

Short title

This Act may be cited as the Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 or the PATIENTS Act of 2011.

2.

Prohibition on Certain Uses of Data Obtained from Comparative Effectiveness Research; Accounting for Personalized Medicine and Differences in Patient Treatment Response

(a)

In general

Notwithstanding any other provision of law, the Secretary of Health and Human Services—

(1)

shall not use data obtained from the conduct of comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009 (Public Law 111–5) or authorized or appropriated under the Patient Protection and Affordable Care Act (Public Law 111–148), to deny or delay coverage of an item or service under a Federal health care program (as defined in section 1128B(f) of the Social Security Act (42 U.S.C. 1320a–7b(f))); and

(2)

shall ensure that comparative effectiveness research conducted or supported by the Federal Government accounts for factors contributing to differences in the treatment response and treatment preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.

(b)

Rule of construction

Nothing in this section shall be construed as affecting the authority of the Commissioner of Food and Drugs under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act.